Randomized, Open Label Multi-Center Study Comparing Cabazitaxel at 20 mg/m2 and at 25 mg/m2 Every 3 Weeks in Combination with Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer Previously Treated... (Proselica)

  • Ford, Daniel (Principal Investigator)
  • Stubbs, Clive (Co-Investigator)

Project Details

Short titleRandomized, Open Label Multi-Center Study Comparing Cabazitaxel at 20 mg/m2 and at 25 mg/m2 Every 3 Weeks in Combination with Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer Previously Treated... (Proselica)
StatusFinished
Effective start/end date1/08/11 → 30/06/18

Funding

  • Sandwell & West Birmingham Hospitals